CARDIOVASCULAR SYSTEMS INC (CSII) Stock Fundamental Analysis

NASDAQ:CSII • US1416191062

20 USD
+0.03 (+0.15%)
At close: Apr 27, 2023
20 USD
0 (0%)
After Hours: 4/27/2023, 8:22:19 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

CSII gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While CSII seems to be doing ok healthwise, there are quite some concerns on its profitability. CSII is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CSII had negative earnings in the past year.
  • CSII had a negative operating cash flow in the past year.
CSII Yearly Net Income VS EBIT VS OCF VS FCFCSII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -20M -40M

1.2 Ratios

  • The profitability ratios for CSII are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSII Yearly ROA, ROE, ROICCSII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -10 -20 -30 -40 -50

1.3 Margins

  • Looking at the Gross Margin, with a value of 72.39%, CSII belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
  • CSII's Gross Margin has declined in the last couple of years.
  • CSII does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.96%
CSII Yearly Profit, Operating, Gross MarginsCSII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CSII does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CSII has more shares outstanding
  • CSII has a worse debt/assets ratio than last year.
CSII Yearly Shares OutstandingCSII Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
CSII Yearly Total Debt VS Total AssetsCSII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

  • CSII has an Altman-Z score of 6.06. This indicates that CSII is financially healthy and has little risk of bankruptcy at the moment.
  • CSII's Altman-Z score of 6.06 is amongst the best of the industry. CSII outperforms 80.57% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that CSII is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.08, CSII perfoms like the industry average, outperforming 58.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 6.06
ROIC/WACCN/A
WACC9.65%
CSII Yearly LT Debt VS Equity VS FCFCSII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 6.04 indicates that CSII has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 6.04, CSII is in the better half of the industry, outperforming 72.99% of the companies in the same industry.
  • CSII has a Quick Ratio of 4.92. This indicates that CSII is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CSII (4.92) is better than 72.04% of its industry peers.
Industry RankSector Rank
Current Ratio 6.04
Quick Ratio 4.92
CSII Yearly Current Assets VS Current LiabilitesCSII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CSII shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.97%.
  • Looking at the last year, CSII shows a decrease in Revenue. The Revenue has decreased by -4.73% in the last year.
  • Measured over the past years, CSII shows a small growth in Revenue. The Revenue has been growing by 2.89% on average per year.
EPS 1Y (TTM)-46.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-1.61%
Revenue growth 5Y2.89%
Sales Q2Q%3.92%

3.2 Future

  • Based on estimates for the next years, CSII will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.08% on average per year.
  • The Revenue is expected to grow by 10.69% on average over the next years. This is quite good.
EPS Next Y28.21%
EPS Next 2Y21.47%
EPS Next 3Y19.08%
EPS Next 5YN/A
Revenue Next Year8.64%
Revenue Next 2Y9.57%
Revenue Next 3Y10.69%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CSII Yearly Revenue VS EstimatesCSII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CSII Yearly EPS VS EstimatesCSII Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSII. In the last year negative earnings were reported.
  • Also next year CSII is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSII Price Earnings VS Forward Price EarningsCSII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSII Per share dataCSII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CSII's earnings are expected to grow with 19.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.47%
EPS Next 3Y19.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CSII does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CARDIOVASCULAR SYSTEMS INC

NASDAQ:CSII (4/27/2023, 8:22:19 PM)

After market: 20 0 (0%)

20

+0.03 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-03
Earnings (Next)07-31
Inst Owners0%
Inst Owner Change0%
Ins Owners5.24%
Ins Owner Change0%
Market Cap839.18M
Revenue(TTM)239.84M
Net Income(TTM)-37.87M
Analysts48.33
Price Target17.75 (-11.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.68%
Min EPS beat(2)-28.27%
Max EPS beat(2)-15.09%
EPS beat(4)1
Avg EPS beat(4)-10.65%
Min EPS beat(4)-28.27%
Max EPS beat(4)13.04%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.79%
Min Revenue beat(2)-4.49%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-4.49%
Max Revenue beat(4)-1.09%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.9%
EPS NY rev (1m)0%
EPS NY rev (3m)1.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.5
P/FCF N/A
P/OCF N/A
P/B 3.51
P/tB 3.74
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS5.72
BVpS5.71
TBVpS5.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.39%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.25%
GM growth 5Y-1.96%
F-Score2
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 90.93%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.04
Quick Ratio 4.92
Altman-Z 6.06
F-Score2
WACC9.65%
ROIC/WACCN/A
Cap/Depr(3y)91.15%
Cap/Depr(5y)90.95%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.04%
EPS Next Y28.21%
EPS Next 2Y21.47%
EPS Next 3Y19.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-1.61%
Revenue growth 5Y2.89%
Sales Q2Q%3.92%
Revenue Next Year8.64%
Revenue Next 2Y9.57%
Revenue Next 3Y10.69%
Revenue Next 5YN/A
EBIT growth 1Y-41.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.76%
EBIT Next 3Y32.49%
EBIT Next 5YN/A
FCF growth 1Y-111.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-154.42%
OCF growth 3YN/A
OCF growth 5YN/A

CARDIOVASCULAR SYSTEMS INC / CSII FAQ

What is the fundamental rating for CSII stock?

ChartMill assigns a fundamental rating of 3 / 10 to CSII.


Can you provide the valuation status for CARDIOVASCULAR SYSTEMS INC?

ChartMill assigns a valuation rating of 1 / 10 to CARDIOVASCULAR SYSTEMS INC (CSII). This can be considered as Overvalued.


What is the profitability of CSII stock?

CARDIOVASCULAR SYSTEMS INC (CSII) has a profitability rating of 0 / 10.


What is the financial health of CARDIOVASCULAR SYSTEMS INC (CSII) stock?

The financial health rating of CARDIOVASCULAR SYSTEMS INC (CSII) is 6 / 10.